BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12063087)

  • 1. Central effects of 1,4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid.
    Carai MA; Colombo G; Reali R; Serra S; Mocci I; Castelli MP; Cignarella G; Gessa GL
    Eur J Pharmacol; 2002 Apr; 441(3):157-63. PubMed ID: 12063087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid.
    Carai MA; Colombo G; Brunetti G; Melis S; Serra S; Vacca G; Mastinu S; Pistuddi AM; Solinas C; Cignarella G; Minardi G; Gessa GL
    Eur J Pharmacol; 2001 Oct; 428(3):315-21. PubMed ID: 11689189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gamma-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABA(B) receptors.
    Nava F; Carta G; Bortolato M; Gessa GL
    Eur J Pharmacol; 2001 Nov; 430(2-3):261-3. PubMed ID: 11711039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid.
    Castelli MP; Ferraro L; Mocci I; Carta F; Carai MA; Antonelli T; Tanganelli S; Cignarella G; Gessa GL
    J Neurochem; 2003 Nov; 87(3):722-32. PubMed ID: 14535954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel gamma-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonists.
    Carter LP; Wu H; Chen W; Matthews MM; Mehta AK; Hernandez RJ; Thomson JA; Ticku MK; Coop A; Koek W; France CP
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1314-23. PubMed ID: 15769868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-aminobutyric acidB (GABAB)-receptor mediation of different in vivo effects of gamma-butyrolactone.
    Carai MA; Lobina C; Maccioni P; Cabras C; Colombo G; Gessa GL
    J Pharmacol Sci; 2008 Feb; 106(2):199-207. PubMed ID: 18270475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme and receptor antagonists for preventing toxicity from the gamma-hydroxybutyric acid precursor 1,4-butanediol in CD-1 mice.
    Quang LS; Desai MC; Kraner JC; Shannon MW; Woolf AD; Maher TJ
    Ann N Y Acad Sci; 2002 Jun; 965():461-72. PubMed ID: 12105121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo conversion of gamma-aminobutyric acid and 1,4-butanediol to gamma-hydroxybutyric acid in rat brain. Studies using stable isotopes.
    Snead OC; Furner R; Liu CC
    Biochem Pharmacol; 1989 Dec; 38(24):4375-80. PubMed ID: 2604740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: evidence for GABA(B) receptor-mediated effects.
    Pistis M; Muntoni AL; Pillolla G; Perra S; Cignarella G; Melis M; Gessa GL
    Neuroscience; 2005; 131(2):465-74. PubMed ID: 15708487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies.
    Carter LP; Flores LR; Wu H; Chen W; Unzeitig AW; Coop A; France CP
    J Pharmacol Exp Ther; 2003 May; 305(2):668-74. PubMed ID: 12606639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABA(B) receptor-mediated increase of neurosteroids by gamma-hydroxybutyric acid.
    Barbaccia ML; Colombo G; Affricano D; Carai MA; Vacca G; Melis S; Purdy RH; Gessa GL
    Neuropharmacology; 2002 May; 42(6):782-91. PubMed ID: 12015204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resuscitative treatments on 1,4-butanediol mortality in mice.
    Carai MA; Colombo G; Quang LS; Maher TJ; Gessa GL
    Ann Emerg Med; 2006 Feb; 47(2):184-9. PubMed ID: 16431232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats.
    Carai MA; Quang LS; Atzeri S; Lobina C; Maccioni P; OrrĂ¹ A; Gessa GL; Maher TJ; Colombo G
    Brain Res Brain Res Protoc; 2005 Jul; 15(2):75-8. PubMed ID: 15886053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,4 Butanediol, gamma-hydroxybutyric acid and ethanol: relationships and interactions.
    Poldrugo F; Snead OC
    Neuropharmacology; 1984 Jan; 23(1):109-113. PubMed ID: 6717752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate receptor in the rat brain.
    Castelli MP; Mocci I; Pistis M; Peis M; Berta D; Gelain A; Gessa GL; Cignarella G
    Eur J Pharmacol; 2002 Jun; 446(1-3):1-5. PubMed ID: 12098579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA(B)-receptor mediation of the inhibitory effect of gamma-hydroxybutyric acid on intestinal motility in mice.
    Carai MA; Agabio R; Lobina C; Reali R; Vacca G; Colombo G; Gessa GL
    Life Sci; 2002 May; 70(25):3059-67. PubMed ID: 12138019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) in rats discriminating GHB from baclofen and diazepam.
    Koek W; Carter LP; Lamb RJ; Chen W; Wu H; Coop A; France CP
    J Pharmacol Exp Ther; 2005 Jul; 314(1):170-9. PubMed ID: 15774716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice.
    Kaupmann K; Cryan JF; Wellendorph P; Mombereau C; Sansig G; Klebs K; Schmutz M; Froestl W; van der Putten H; Mosbacher J; Bräuner-Osborne H; Waldmeier P; Bettler B
    Eur J Neurosci; 2003 Nov; 18(10):2722-30. PubMed ID: 14656321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous gamma-aminobutyric acid (GABA)(A) receptor active neurosteroids and the sedative/hypnotic action of gamma-hydroxybutyric acid (GHB): a study in GHB-S (sensitive) and GHB-R (resistant) rat lines.
    Barbaccia ML; Carai MA; Colombo G; Lobina C; Purdy RH; Gessa GL
    Neuropharmacology; 2005 Jul; 49(1):48-58. PubMed ID: 15992580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of GABA(B) receptor function in vivo by disulfide reducing agent, DL-dithiothreitol (DTT).
    Carai MA; Vacca G; Serra S; Colombo G; Froestl W; Gessa GL
    Psychopharmacology (Berl); 2004 Jul; 174(2):283-90. PubMed ID: 14760512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.